Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice.
Komai M, Tanaka H, Nagao K, Ishizaki M, Kajiwara D, Miura T, Ohashi H, Haba T, Kawakami K, Sawa E, Yoshie O, Inagaki N, Nagai H. Komai M, et al. Among authors: kajiwara d. J Pharmacol Sci. 2010;112(2):203-13. doi: 10.1254/jphs.09277fp. Epub 2010 Feb 4. J Pharmacol Sci. 2010. PMID: 20134116 Free article.
Experimentally induced eosinophilic polyps in rabbit sinuses.
Sejima T, Kajiwara D, Kikuchi H, Imayoshi S, Yamauchi T, Ichimura K. Sejima T, et al. Among authors: kajiwara d. Am J Rhinol Allergy. 2010 Sep-Oct;24(5):341-7. doi: 10.2500/ajra.2010.24.3519. Am J Rhinol Allergy. 2010. PMID: 21244733
Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis.
Aoyagi H, Kajiwara D, Tsunekuni K, Tanaka K, Miyoshi K, Hirasawa N. Aoyagi H, et al. Among authors: kajiwara d. Eur J Pharmacol. 2020 May 15;875:173030. doi: 10.1016/j.ejphar.2020.173030. Epub 2020 Feb 19. Eur J Pharmacol. 2020. PMID: 32084417
Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor.
Kajiwara D, Kamoda H, Yonemoto T, Iwata S, Ishii T, Tsukanishi T, Ohtori S, Yamazaki M, Okawa A. Kajiwara D, et al. Asian Spine J. 2016 Jun;10(3):553-7. doi: 10.4184/asj.2016.10.3.553. Epub 2016 Jun 16. Asian Spine J. 2016. PMID: 27340537 Free PMC article.
23 results